Zachary Smith to Gastrointestinal Agents
This is a "connection" page, showing publications Zachary Smith has written about Gastrointestinal Agents.
Connection Strength
0.235
-
Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III Trials. J Crohns Colitis. 2025 Feb 04; 19(2).
Score: 0.235